You have 9 free searches left this month | for more free features.

Genomic alteration

Showing 1 - 25 of 2,104

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Genomic Alteration in Luminal A or Luminal B Subtypes

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022

    Metastatic Cancers Trial in France (Blood sampling)

    Completed
    • Metastatic Cancers
    • Blood sampling
    • Amiens, France
    • +35 more
    Sep 5, 2022

    Soft Tissue Sarcoma Trial in France (drug, combination product, other)

    Recruiting
    • Soft Tissue Sarcoma
    • Bordeaux, France
    • +17 more
    Oct 4, 2022

    Intrahepatic Cholangiocarcinoma Trial (derazantinib)

    Available
    • Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Jan 13, 2023

    Solid Tumor, Unspecified, Adult Trial in Villejuif (Biopsy)

    Recruiting
    • Solid Tumor, Unspecified, Adult
    • Biopsy
    • Villejuif, Val De Marne, France
      Gustave Roussy Cancer Campus Grand Paris
    Sep 3, 2021

    Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Newly obtained biopsy and Blood samples collection
    • Bayonne, France
    • +5 more
    Feb 1, 2022

    Radiomics for prEdiction of lunG cAncer biologY

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • PET/CT
    • Poitiers, France
      CHU Poitiers
    Apr 5, 2023

    Rare Malignant Tumor Trial in Chuo-ku

    Recruiting
    • Rare Malignant Neoplasm
      • Chuo-ku, Tokyo, Japan
        National Cancer Center Hospital, Japan
      Jan 19, 2022

      NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Avitinib Maleate
      • +13 more
      • Guangzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong Provincial People's H
      Dec 3, 2022

      Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

      Recruiting
      • Locally Advanced Leiomyosarcoma
      • +5 more
      • New York, New York
        Columbia University/Herbert Irving Cancer Center
      Jan 4, 2023

      Brain Metastases Trial (biological samples (blood test and lumbar puncture))

      Not yet recruiting
      • Brain Metastases
      • biological samples (blood test and lumbar puncture)
      • (no location specified)
      May 4, 2023

      Alteration of Symbiosis Intestinal Microbiota on Anorexia

      Not yet recruiting
      • Anorexia Nervosa
      • +2 more
      • Stool sample
      • Villejuif, France
        Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)
      Nov 21, 2022

      Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)

      Recruiting
      • Salivary Gland Neoplasms
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
      Oct 8, 2021

      Bile cfDNA of Resectable Biliary Tract Carcinomas

      Recruiting
      • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
      • Next generation sequencing
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
      Mar 13, 2023

      PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • ctDNA liquid biopsy - Roche Avenio Assay
      • (no location specified)
      Sep 14, 2022

      Advanced or Poor Prognosis Cancers

      Active, not recruiting
      • Cancer
        • La Jolla, California
        • +1 more
        Feb 17, 2022

        Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH), Non-Langerhans-Cell Histiocytosis Trial in Cleveland (Genetic

        Recruiting
        • Castleman's Disease (CD)
        • +2 more
        • Genetic testing
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        Jun 21, 2022

        Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

        Not yet recruiting
        • Locally Advanced Leiomyosarcoma
        • +8 more
        • (no location specified)
        Jul 6, 2022

        Liquid Biopsy-informed Precision Oncology Study to Evaluate

        Not yet recruiting
        • Solid Tumor
        • Non-invasive Comprehensive Genomic Profiling for Cancer Treatment Selection
        • Baltimore, Maryland
          Johns Hopkins University
        Jan 27, 2023

        Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

        Recruiting
        • Neurofibromatosis 1
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

        Active, not recruiting
        • Solid Tumors
        • +2 more
        • Paris, France
          Tredaniel
        May 18, 2022

        Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

        Recruiting
        • Metastatic Prostate Cancer
        • Liquid Biopsy
        • Archival Tumor DNA sequencing
        • Barcelona, Spain
          SOLTI Cancer Research Group
        May 22, 2023

        NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

        Active, not recruiting
        • Non-small Cell Lung Cancer Metastatic
        • Avignon, France
        • +36 more
        Jul 29, 2022

        Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

        Active, not recruiting
        • Malignant Solid Neoplasm
        • Biopsy
        • +5 more
        • Philadelphia, Pennsylvania
          ECOG-ACRIN Cancer Research Group
        Nov 15, 2023